Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China

PURPOSE: Tiotropium/olodaterol (TIO/OLO) fixed-dose combination (FDC) can improve lung function and quality of life for patients with chronic obstructive pulmonary disease (COPD), and is not inferior to other LAMA/LABAs. The aim of this study was to assess the cost-effectiveness of TIO/OLO FDC in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Ying, Yang, Nan, Wang, Yirong, Yang, Yan, Xu, Min, He, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520256/
https://www.ncbi.nlm.nih.gov/pubmed/37767047
http://dx.doi.org/10.2147/COPD.S425409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520256/
https://www.ncbi.nlm.nih.gov/pubmed/37767047
http://dx.doi.org/10.2147/COPD.S425409

Ejemplares similares